StockWatch
·
Biotechnology: Laboratory Analytical Instruments
Corporate GovernanceJun 22, 2026, 07:11 AM

EyePoint Stockholders Approve 4.9M Share Increase for Incentive Plan

AI Summary

EyePoint, Inc. stockholders approved an amendment to the 2023 Long-Term Incentive Plan, increasing the number of shares authorized for issuance by 4,900,000. This approval occurred at the 2026 Annual Meeting, where shareholders also elected eight directors, provided a non-binding advisory approval for named executive officer compensation, and ratified Deloitte & Touche LLP as the independent auditor for fiscal year 2026.

Key Highlights

  • Stockholders approved an increase of 4,900,000 shares for the 2023 Long-Term Incentive Plan.
  • 71,010,327 shares, or 84.74% of outstanding shares, were present or voted at the meeting.
  • Eight directors were elected to the Board.
  • The plan amendment was approved with 49,662,176 votes For and 13,010,393 Against.
  • Named executive officer compensation received 60,563,563 votes For in a non-binding advisory vote.
  • Deloitte & Touche LLP's appointment as auditor was ratified with 70,608,563 votes For.